EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

APOBEC3 antagonism fully explains HIV-1 Vif essentiality in THP-1 cells under interferon and differentiation conditions

Ryo Shimizu, Michael Jonathan, Hiromi Terasawa, Akatsuki Saito iD, Kazuaki Monde iD, Terumasa Ikeda iD

Journal of Virology · 10.11.2026

DOI: 10.1128/jvi.00671-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, online erschienen am 10.11.2026. Verfasst von Ryo Shimizu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HIV-1 virion infectivity factor (Vif) counteracts APOBEC3 (A3) proteins by targeting them for proteasomal degradation, thereby preventing lethal G-to-A mutations and loss of infectivity. However, Vif also degrades additional cellular proteins, raising the possibility that its essential role in infectious virion production may extend beyond A3 antagonism, particularly under inflammatory or differentiation conditions. Whether such conditions reveal additional essential Vif targets remains unresolved. Here, using interferon (IFN)-stimulated or phorbol 12-myristate 13-acetate (PMA)-differentiated THP-1 monocytic cells, we directly addressed this question. Although type I IFN and PMA markedly suppressed viral production through Vif-independent mechanisms, ΔVif viruses produced from stimulated parental cells exhibited severely reduced infectivity. In contrast, disruption of A3A-A3G fully restored ΔVif infectivity to wild-type levels under all conditions tested. G-to-A mutations were attributable exclusively to A3 proteins under both IFN and PMA stimulation, whereas IFN-induced, A3-independent blocks to reverse transcription were not antagonized by Vif. Moreover, Vif-mediated degradation of the non-A3 targets PPP2R5 family proteins did not measurably contribute to virion infectivity under these conditions. Across diverse HIV-1 strains, the requirement for Vif in this experimental system was strictly dependent on A3 family proteins. These findings indicate that, under the conditions examined here, the essential role of Vif is fully explained by antagonism of A3-mediated restriction. Our results further suggest that counteracting A3-mediated restriction and mutagenesis represents a major evolutionary pressure shaping Vif. IMPORTANCE A3 proteins are potent intrinsic antiviral factors that restrict HIV-1 by inducing lethal mutations and impairing reverse transcription. The viral protein Vif counteracts A3-mediated restriction, yet it also targets additional host proteins, raising questions about whether its essential role extends beyond A3 antagonism under inflammatory conditions. Myeloid cells mount interferon (IFN) responses and undergo transcriptional reprogramming upon differentiation, environments in which additional Vif functions could emerge. Using an A3A-A3G-null monocytic cell model, we show that even under IFN stimulation or phorbol 12-myristate 13-acetate (PMA)-induced differentiation, the requirement for Vif in maintaining HIV-1 infectivity is due to A3 proteins. In contrast, Vif does not counteract IFN-induced, A3-independent restriction pathways, highlighting functional specificity. These findings establish the A3-Vif axis as the central determinant of Vif dependency and suggest that counteracting A3-mediated restriction and mutagenesis represents a major evolutionary pressure shaping Vif. Targeting Vif may therefore expose HIV-1 to intrinsic inactivation, even in inflammatory environments.

Schlagwörter

Stichwörter der Autor:innen

APOBEC3HIV-1IFNPMAVifdeaminase-dependent mechanismdeaminase-independent mechanism

Autor:innen und Institutionen

  • Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
  • Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Department of Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Laboratory for Viral Infection Control, Frontier Science Research Center, University of Miyazaki, Miyazaki, Japan.
  • Department of Veterinary Medicine, University of Miyazaki, Miyazaki, Japan.
  • Center for Animal Disease Control, University of Miyazaki, Miyazaki, Japan.

ORCID-Profile: Akatsuki Saito, Kazuaki Monde, Terumasa Ikeda

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Zitieren

APA

Shimizu, R., Jonathan, M., Terasawa, H., Saito, A., Monde, K., & Ikeda, T. (2026). APOBEC3 antagonism fully explains HIV-1 Vif essentiality in THP-1 cells under interferon and differentiation conditions. Journal of Virology. https://doi.org/10.1128/jvi.00671-26

Vancouver

Shimizu R, Jonathan M, Terasawa H, Saito A, Monde K, Ikeda T. APOBEC3 antagonism fully explains HIV-1 Vif essentiality in THP-1 cells under interferon and differentiation conditions. Journal of Virology. 2026. doi:10.1128/jvi.00671-26

BibTeX
@article{Shimizu2026,
  author = {Shimizu, Ryo and Jonathan, Michael and Terasawa, Hiromi and Saito, Akatsuki and Monde, Kazuaki and Ikeda, Terumasa},
  title = {APOBEC3 antagonism fully explains HIV-1 Vif essentiality in THP-1 cells under interferon and differentiation conditions},
  journal = {Journal of Virology},
  year = {2026},
  doi = {10.1128/jvi.00671-26}
}
Kostenlos starten →